Synthetic molecule kills cancer cells with salt
http://www.nanowerk.com/news2/biotech/newsid=36893.php

Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells
http://www.nature.com/nchem/journal/vaop/ncurrent/full/nchem.2021.html

Bacterial biosurgery shows promise for reducing the size of inoperable tumors
http://www.nanowerk.com/news2/biotech/newsid=36926.php

Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses
http://stm.sciencemag.org/content/6/249/249ra111

Synthetic molecule makes cancer self-destruct
http://www.nanowerk.com/news2/biotech/newsid=36877.php

Uh-oh, IBM's Watson is back.

IBM Watson Speeds Drug Research

"As part of Baylor's research, Watson analyzed more than 70,000 scientific articles related to p53, a protein that has been linked to many cancers. Automated analysis carried out by Watson helped Baylor biologists and data scientists identify six proteins that modify p53 and that should be targeted for new research. Most important, the discovery was made in a matter of weeks, according to IBM."

"Where Watson stands out, according to IBM, is its cognitive computing understanding of language and chemistry to make human-like leaps in understanding at computer-analysis speeds."

Looks like WCG has some competition (I mean that in a good way).

[Imported, feral, Hawaiian] Cane toad poison attacks prostate cancer cells, spares healthy cells: [Australian] Queensland university researchers.

https://au.news.yahoo.com/qld/a/25017088/cane...d-university-researchers/

Google searching for cancer cure
The company announced Tuesday that it is experimenting with designing nanoparticles that would detect cancer and other diseases before their onset.
http://money.cnn.com/2014/10/28/technology/google-cancer/index.html

CJSL

Crunching for a brighter future...

Promising results from world-first brain cancer trials

Scientists at the QIMR Berghofer Medical Research Institute have used immunotherapy to make a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM).

Study leader, Professor Rajiv Khanna, said most of the study participants lived much longer than the six-month prognosis normally given to a patient with recurrent GBM, and some patients showed no signs of disease progression.

“It is early days, but this is exciting,” Professor Khanna said. “Survival rates for this aggressive cancer have barely changed in decades. There is an urgent clinical need for new treatments. “If this treatment can buy patients more time, then that is a big step forward.”

GBM is the most common malignant brain cancer, diagnosed in about 800 Australians every year. Despite surgery, radiotherapy and chemotherapy, less than 10% of patients survive beyond five years.

This study built on previous research which found that many brain tumours carry cytomegalovirus (CMV). About half of all Australians have the virus, but usually show no symptoms. Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body. When the killer T-cells destroyed the virus, they also destroyed the cancer.

More at http://www.qimrberghofer.edu.au/page/News__Ev...irst_brain_cancer_trials/